Molecular imaging biomarkers for immune checkpoint inhibitor therapy

Immune checkpoint inhibitors (ICIs) have substantially changed the field of oncology over the past few years. ICIs offer an alternative treatment strategy by exploiting the patients' immune system, resulting in a T cell mediated anti-tumor response. These therapies are effective in multiple dif...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Theranostics
Autors principals: van de Donk, Pim P, Kist de Ruijter, Laura, Lub-de Hooge, Marjolijn N, Brouwers, Adrienne H, van der Wekken, Anthonie J, Oosting, Sjoukje F, Fehrmann, Rudolf SN, de Groot, Derk Jan A, de Vries, Elisabeth GE
Format: Artigo
Idioma:Inglês
Publicat: Ivyspring International Publisher 2020
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6993216/
https://ncbi.nlm.nih.gov/pubmed/32042331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.38339
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars